For Healthcare Professionals

About the Registry

Help us better understand the potential impact of migraine medication exposure on pregnancy outcomes.

As part of Teva’s commitment to improving the lives of patients, the Teva Migraine Pregnancy Registry has been established in the US to collect information on pregnancy outcomes of women who suffer from migraine and have been exposed to migraine medication during pregnancy.

Help us in enrolling women who have been exposed to migraine medications during or within the five months prior to their current pregnancy. Pregnant women may enroll themselves by calling the toll-free Registry hotline at 833-927-2605, or you may complete the enrollment forms and email or fax them back to the Registry on behalf of the patient.

If you have a patient who you think may qualify or if you have any questions about the Teva Migraine Pregnancy Registry, please click here or call 833-927-2605.
Background of the Teva Migraine Pregnancy Registry
There is an unmet need for women who experience migraine during pregnancy.

There is currently only limited clinical data on the risk associated with the use of migraine medications in pregnant women. Since migraine is prevalent in women of childbearing potential and approximately half of all pregnancies are unplanned, women may inadvertently be exposed to migraine medications during pregnancy.1 Monitoring and evaluating these pregnant women can help in assessing the impact of migraine medication exposure on pregnancy outcomes.

Purpose of the Teva Migraine Pregnancy Registry

The aim of the Teva Migraine Pregnancy Registry is to assess the maternal, fetal, and infant outcomes in the following groups of women:

  • Women with migraine who are exposed to anti-CGRP monoclonal antibody preventive treatments for migraine
  • Women with migraine who are exposed to non-CGRP-pathway-targeting long-term migraine medications
What is involved for participants?
Data Collection by Registry

Data will be collected from patients or healthcare providers via phone interviews conducted by registry staff, online questionnaires, paper-based case report forms (CRFs), or a combination of these methods.

Download enrollment forms here
Patient Eligibility
Registry Eligibility Criteria

The Teva Migraine Pregnancy Registry is enrolling pregnant women with migraine,
aged 18 to 45 years, meeting the criteria for one of the following groups:

01.

Women exposed to at least one dose of anti-CGRP monoclonal antibody at any time during pregnancy or within the five months prior to their current pregnancy

02.

Women exposed to preventive migraine medications other than CGRP-pathway-targeting medication at any time during pregnancy or within 21 days prior to LMP

Enroll a Patient
How to enroll your patient

If you have a patient who you think may qualify or if you have any questions about the Teva Migraine Pregnancy Registry, please click here, or call the Registry Hotline at the number below.

Download Patient Brochure, Email Template, & HCP Study Card

Teva Migraine Pregnancy Registry

Registry Phone Number: 833-927-2605

Registry Fax Number: 800-800-1052

TevaMigrainePregnancyRegistry@syneoshealth.com